March 21st 2024
GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Many Ob/Gyns Continue Outdated Cervical Cancer Screening Practices
July 19th 2013Despite new screening guidelines, most obstetrician-gynecologists continue to perform annual pap tests, according to a recent survey of members of the American Congress of Obstetricians and Gynecologists (ACOG).
Read More
Signs, Symptoms and Screening for Ovarian Cancer
June 26th 2013New research shows that symptoms exist in even early-stage ovarian cancer, disproving the myth that it's a "silent killer." Barbara Goff, MD, presents the latest in symptom research, tips on what physicians should be looking for, and what's on the horizon for ovarian cancer screening.
Read More
PET Scan Not Cost Effective for Diagnosing Recurrent Cervical Cancer
June 19th 2013The addition of positron emission tomography/computed tomography (PET-CT) for the diagnosis of recurrent or persistent cervical cancer is not cost-effective, according to the results of a meta-analysis funded by the UK’s Research Health Technology Assessment program.
Read More
Vinegar holds promise for cervical cancer screening
June 6th 2013A test for cervical cancer that uses ordinary vinegar--and that can be performed by trained laypersons--holds promise for poor countries where cytology-based screening is not easily implemented. This low-cost, innovative solution to a pressing women’s health problem was presented at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Read More
Bevacizumab Improves Survival but Reduces Quality of Life in Late-Stage Cancer Patients
March 18th 2013Patients with stage IVB, recurrent, or persistent cervical cancer that was not cured with standard treatment who were given the angiogenesis inhibitor bevacizumab lived 3.7 months longer than patients who did not receive the drug, but adverse events increased.
Read More
SGO focus: IP therapy has long-term benefit in ovarian cancer
March 14th 2013A meta-analysis of two Gynecologic Oncology Group (GOG) clinical trials shows a clear long-term survival benefit for intraperitoneal (IP) therapy over intravenous (IV) treatment of ovarian cancer. The results were presented at the 2013 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in Los Angeles.
Read More
mRNA-Based HPV Assay Performs Well for Triaging Colposcopy Referrals
February 22nd 2013The use of APTIMA human papillomavirus (AHPV) assay for the detection of high-risk human papillomavirus E6/E7 oncogenic messenger RNA is an effective triage method for colposcopy referral in women with atypical squamous cells of undetermined significance cytology (ASC-US).
Read More
The Leadership Report: The Best Ob/Gyn Research From 2012
February 14th 2013From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.
Read More
New Medical Guidelines for Cervical Cancer Screening: Is there a role for new molecular diagnostics?
January 31st 2013Some may argue that the new ACOG, ACS and other cervical cancer screening guidelines will detect the majority of at-risk women. We should not be content with settling for identifying a majority of at risk women; rather, we should constantly reassess the availability of useful tests to see if we can improve reliability.
Read More
New Finding Holds Promise for Future Targeted Treatment of Ovarian Cancer
January 22nd 2013Using sophisticated gene sequencing methods, researchers at Yale School of Medicine have demonstrated a regulatory link between stem cell factors that fuel the growth of ovarian cancer and the prognosis of patients, according to a new report.
Read More
Exercise Combats Fatigue During and After Cancer Treatment
December 28th 2012The effects of exercise during and after cancer treatment are different, according to the findings of a new systematic review. Researchers concluded that exercise has a palliative effect in patients during cancer treatment and a recuperative effect after treatment.
Read More
IUD May Effectively Treat Early-Stage Endometrial Cancer
November 12th 2012An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.
Read More
Research Supports Laparoscopic Hysterectomy for Early Endometrial Cancer
October 19th 2012A review comparing laparoscopic hysterectomy versus abdominal hysterectomy for early-stage endometrial cancer has found that rates of overall survival and disease-free survival are similar for the surgical procedures.
Read More
Lapatinib Plus Trastuzumab Improves Survival in Metastatic Breast Cancer
August 20th 2012In patients with heavily pretreated HER2-positive metastatic breast cancer, combination treatment with lapatinib and trastuzumab was associated with a median survival benefit of 4.5 months, according to the final results of a phase III study.
Read More